Literature DB >> 27195470

Applying Adult Ventilator-associated Pneumonia Bundle Evidence to the Ventilated Neonate.

Carla D Weber1.   

Abstract

BACKGROUND: Ventilator-associated pneumonia (VAP) in neonates can be reduced by implementing preventive care practices. Implementation of a group, or bundle, of evidence-based practices that improve processes of care has been shown to be cost-effective and to have better outcomes than implementation of individual single practices.
PURPOSE: The purpose of this article is to describe a safe, effective, and efficient neonatal VAP prevention protocol developed for caregivers in the neonatal intensive care unit (NICU). Improved understanding of VAP causes, effects of care practices, and rationale for interventions can help reduce VAP risk to neonatal patients.
METHOD: In order to improve care practices to affect VAP rates, initial and annual education occurred on improved protocol components after surveying staff practices and auditing documentation compliance. FINDINGS/
RESULTS: In 2009, a tertiary care level III NICU in the Midwestern United States had 14 VAP cases. Lacking evidence-based VAP prevention practices for neonates, effective adult strategies were modified to meet the complex needs of the ventilated neonate. A protocol was developed over time and resulted in an annual decrease in VAP until rates were zero for 20 consecutive months from October 2012 to May 2014. IMPLICATIONS FOR PRACTICE: This article describes a VAP prevention protocol developed to address care practices surrounding hand hygiene, intubation, feeding, suctioning, positioning, oral care, and respiratory equipment in the NICU. IMPLICATIONS FOR RESEARCH: Implementation of this VAP prevention protocol in other facilities with appropriate monitoring and tracking would provide broader support for standardization of care. Individual components of this VAP protocol could be studied to strengthen the inclusion of each; however, bundled interventions are often considered stronger when implemented as a whole.

Entities:  

Mesh:

Year:  2016        PMID: 27195470     DOI: 10.1097/ANC.0000000000000276

Source DB:  PubMed          Journal:  Adv Neonatal Care        ISSN: 1536-0903            Impact factor:   1.968


  6 in total

1.  Ventilator-associated pneumonia in neonates: the role of point of care lung ultrasound.

Authors:  Nora Tusor; Angela De Cunto; Yousef Basma; John L Klein; Virginie Meau-Petit
Journal:  Eur J Pediatr       Date:  2020-06-26       Impact factor: 3.183

2.  Neonatal Ventilator Associated Pneumonia: A Quality Improvement Initiative Focusing on Antimicrobial Stewardship.

Authors:  Anouk Goerens; Dirk Lehnick; Michael Büttcher; Karin Daetwyler; Matteo Fontana; Petra Genet; Marco Lurà; Davide Morgillo; Sina Pilgrim; Katharina Schwendener-Scholl; Nicolas Regamey; Thomas J Neuhaus; Martin Stocker
Journal:  Front Pediatr       Date:  2018-09-24       Impact factor: 3.418

Review 3.  Pneumonia.

Authors:  Thomas A Hooven; Richard A Polin
Journal:  Semin Fetal Neonatal Med       Date:  2017-03-24       Impact factor: 3.926

Review 4.  [Infection prevention in neonatal intensive care units].

Authors:  Arne Simon; Michael Zemlin; Martina Geipel; Barbara Gärtner; Jakob Armann; Sascha Meyer
Journal:  Gynakologe       Date:  2021-05-04

Review 5.  Practice Summary of Antimicrobial Therapy for Commonly Encountered Conditions in the Neonatal Intensive Care Unit: A Canadian Perspective.

Authors:  Joseph Y Ting; Julie Autmizguine; Michael S Dunn; Julie Choudhury; Julie Blackburn; Shikha Gupta-Bhatnagar; Katrin Assen; Julie Emberley; Sarah Khan; Jessica Leung; Grace J Lin; Destiny Lu-Cleary; Frances Morin; Lindsay L Richter; Isabelle Viel-Thériault; Ashley Roberts; Kyong-Soon Lee; Erik D Skarsgard; Joan Robinson; Prakesh S Shah
Journal:  Front Pediatr       Date:  2022-07-08       Impact factor: 3.569

6.  A glass half-full: defining ventilator-associated pneumonia in the neonatal intensive care unit.

Authors:  Emily D Whitesel; Munish Gupta
Journal:  Pediatr Res       Date:  2020-04-02       Impact factor: 3.756

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.